GILD in the 13F filings
Gilead Sciences Inc · CUSIP 375558103
- Quarter end
- 31 Dec 2024
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 11 Feb 2025
- Managers listing it
- 28
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q3 2024 and Q4 2024; 25 listed it in both
- Shares listed
- 280,733,381
- combined, among listed positions
- Reported value
- $25.9bn
- combined, at the quarter end
Among the 94 comparable managers: 14 buyers (opened or added shares) and 14 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing GILD in Q4 2024
28 of 28 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 40,319,432 shares now+7,157,113
- Invesco Ltdexisting position · 11,277,915 shares now+1,292,399
- Renaissance Technologies LLCexisting position · 5,329,743 shares now+1,141,219
- Wellington Management Group LLPexisting position · 35,659,007 shares now+1,058,331
- D. E. Shaw & Co.existing position · 1,012,462 shares now+271,261
Reductions
- Capital World Investorsexisting position · 71,706,362 shares now-4,842,566
- Capital Research Global Investorsexisting position · 57,946,228 shares now-3,853,443
- Two Sigma Advisers LPexisting position · 270,796 shares now-2,217,004
- Point72 Asset Management LPexisting position · 856,657 shares now-1,448,613
- Woodline Partners LPexisting position · 734,693 shares now-1,193,336
New positions and exits
New (2)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 22 | $26.4bn | n.a. | n.a. |
| Q3 2013 | 20 | $31.7bn | n.a. | n.a. |
| Q4 2013 | 24 | $35.6bn | n.a. | n.a. |
| Q1 2014 | 26 | $30.7bn | n.a. | n.a. |
| Q2 2014 | 26 | $35.5bn | n.a. | n.a. |
| Q3 2014 | 28 | $40.8bn | n.a. | n.a. |
| Q4 2014 | 30 | $30.9bn | n.a. | n.a. |
| Q1 2015 | 32 | $31.9bn | n.a. | n.a. |
| Q2 2015 | 31 | $36.4bn | n.a. | n.a. |
| Q3 2015 | 31 | $27.6bn | n.a. | n.a. |
| Q4 2015 | 34 | $25.0bn | n.a. | n.a. |
| Q1 2016 | 35 | $18.5bn | n.a. | n.a. |
| Q2 2016 | 33 | $15.5bn | n.a. | n.a. |
| Q3 2016 | 30 | $12.9bn | n.a. | n.a. |
| Q4 2016 | 33 | $11.4bn | n.a. | n.a. |
| Q1 2017 | 33 | $9.9bn | n.a. | n.a. |
| Q2 2017 | 33 | $10.4bn | n.a. | n.a. |
| Q3 2017 | 27 | $12.4bn | n.a. | n.a. |
| Q4 2017 | 28 | $12.3bn | n.a. | n.a. |
| Q1 2018 | 32 | $14.0bn | n.a. | n.a. |
| Q2 2018 | 29 | $13.6bn | n.a. | n.a. |
| Q3 2018 | 29 | $15.6bn | n.a. | n.a. |
| Q4 2018 | 32 | $13.3bn | n.a. | n.a. |
| Q1 2019 | 32 | $14.9bn | n.a. | n.a. |
| Q2 2019 | 29 | $16.1bn | n.a. | n.a. |
| Q3 2019 | 30 | $13.9bn | n.a. | n.a. |
| Q4 2019 | 32 | $14.3bn | n.a. | n.a. |
| Q1 2020 | 28 | $17.0bn | n.a. | n.a. |
| Q2 2020 | 23 | $18.7bn | n.a. | n.a. |
| Q3 2020 | 25 | $14.2bn | n.a. | n.a. |
| Q4 2020 | 27 | $13.4bn | n.a. | n.a. |
| Q1 2021 | 24 | $14.5bn | n.a. | n.a. |
| Q2 2021 | 18 | $14.9bn | n.a. | n.a. |
| Q3 2021 | 20 | $16.4bn | n.a. | n.a. |
| Q4 2021 | 20 | $16.8bn | n.a. | n.a. |
| Q1 2022 | 28 | $13.2bn | n.a. | n.a. |
| Q2 2022 | 26 | $13.6bn | n.a. | n.a. |
| Q3 2022 | 24 | $13.3bn | n.a. | n.a. |
| Q4 2022 | 32 | $21.1bn | n.a. | n.a. |
| Q1 2023 | 27 | $21.8bn | n.a. | n.a. |
| Q2 2023 | 24 | $20.7bn | n.a. | n.a. |
| Q3 2023 | 24 | $20.0bn | n.a. | n.a. |
| Q4 2023 | 22 | $21.5bn | 10 | 11 |
| Q1 2024 | 30 | $20.3bn | 17 | 12 |
| Q2 2024 | 28 | $18.5bn | 15 | 14 |
| Q3 2024 | 29 | $24.2bn | 15 | 15 |
| Q4 2024 | 28 | $25.9bn | 14 | 14 |
| Q1 2025 | 33 | $32.0bn | 21 | 12 |
| Q2 2025 | 27 | $30.9bn | 18 | 10 |
| Q3 2025 | 23 | $29.4bn | 9 | 14 |
| Q4 2025 | 25 | $34.3bn | 18 | 19 |
| Q1 2026 | 25 | $38.5bn | 16 | 21 |
| Q2 2026 | 26 | $34.2bn | 22 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GILD and AMGN →GILD and ARGX →GILD and RVMD →Choose a stock to compare with GILD →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GILD, latest filings →Back to the 13F Explorer →